BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Prognosis
30 results:

  • 1. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
    Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
    ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
    Borea F; Franczak MA; Garcia M; Perrino M; Cordua N; Smolenski RT; Peters GJ; Dziadziuszko R; Santoro A; Zucali PA; Giovannetti E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298116
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations.
    Sato T; Akao K; Sato A; Tsujimura T; Mukai S; Sekido Y
    Cancer Med; 2023 Jun; 12(12):13586-13598. PubMed ID: 37165917
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
    Chen-Yost HI; Tjota MY; Gao G; Mitchell O; Kindler H; Segal J; Husain AN; Mueller J; Schulte JJ
    Am J Clin Pathol; 2023 Sep; 160(3):238-246. PubMed ID: 37141416
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
    Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
    Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma.
    Nguyen TT; Lee HS; Burt BM; Amos CI; Cheng C
    Br J Cancer; 2022 Nov; 127(9):1691-1700. PubMed ID: 35999269
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
    Thirusangu P; Ray U; Sarkar Bhattacharya S; Oien DB; Jin L; Staub J; Kannan N; Molina JR; Shridhar V
    Oncogene; 2022 Aug; 41(33):4003-4017. PubMed ID: 35804016
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. schisandrin B suppresses osteosarcoma lung metastasis
    Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
    Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
    Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361
    [No Abstract]    [Full Text] [Related]  

  • 11. Genomic characterization of malignant pleural mesothelioma and associated clinical outcomes.
    Markowitz P; Patel M; Groisberg R; Aisner J; Jabbour SK; De S; Ganesan S; Malhotra J
    Cancer Treat Res Commun; 2020; 25():100232. PubMed ID: 33166854
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Coronary artery bypass grafting in patients with concomitant solid tumours: early and long-term results.
    Garatti A; D'Ovidio M; Saitto G; Daprati A; Canziani A; Mossuto E; D'Oria V; Scarpanti M; De Vincentiis C; Parolari A; Menicanti L
    Eur J Cardiothorac Surg; 2020 Sep; 58(3):528-536. PubMed ID: 32474575
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.
    Taghizadeh H; Zöchbauer-Müller S; Mader RM; Müllauer L; Klikovits T; Bachleitner-Hofmann T; Hoda MA; Prager GW
    Thorac Cancer; 2020 Jul; 11(7):1979-1988. PubMed ID: 32438515
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
    Lu D; Yang J; Liu X; Feng S; Dong X; Shi X; Zhai J; Mai S; Jiang J; Wang Z; Wu H; Cai K
    Cancer Med; 2020 May; 9(10):3455-3462. PubMed ID: 32207885
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.
    Quetel L; Meiller C; Assié JB; Blum Y; Imbeaud S; Montagne F; Tranchant R; de Wolf J; Caruso S; Copin MC; Hofman V; Gibault L; Badoual C; Pintilie E; Hofman P; Monnet I; Scherpereel A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Mol Oncol; 2020 Jun; 14(6):1207-1223. PubMed ID: 32083805
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [SMARCA4-deficient primary thoracic sarcoma:a clinicopathological analysis of five cases].
    Zheng MJ; Zheng Q; Wang Y; Shen L; Zhu XZ; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):537-542. PubMed ID: 31288309
    [No Abstract]    [Full Text] [Related]  

  • 17. The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment.
    Galani V; Varouktsi A; Papadatos SS; Mitselou A; Sainis I; Constantopoulos S; Dalavanga Y
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):241-253. PubMed ID: 31119375
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
    Vivero M; Bueno R; Chirieac LR
    Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Co-occurring Mutations of Tumor Suppressor Genes,
    Tranchant R; Quetel L; Tallet A; Meiller C; Renier A; de Koning L; de Reynies A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
    Clin Cancer Res; 2017 Jun; 23(12):3191-3202. PubMed ID: 28003305
    [No Abstract]    [Full Text] [Related]  

  • 20. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.